Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer

Biochemical Pharmacology

Volumn 98, Issue 1, 2015, Pages 51-68

  Buhrmann, Constanze ^a   Shayan, Parviz ^b,c   Kraehe, Patricia ^a   Popper, Bastian ^a   Goel, Ajay ^d   Shakibaei, Mehdi ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Investigating Institute of Molecular Biological System Transfer   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

5 FU; Claudin 2; Colorectal cancer; E cadherin; Junctions; Resveratrol

Indexed keywords

CASPASE 3; CLAUDIN 2; FLUOROURACIL; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RESVERATROL; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; VIMENTIN; ALGINIC ACID; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; CULTURE MEDIUM; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL CONTACT; CELL INVASION; CELL JUNCTION; CELL PROLIFERATION; CELL SURFACE; CHEMOSENSITIZATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DESMOSOME; DOWN REGULATION; DRUG POTENTIATION; ELECTRON MICROSCOPY; EPITHELIAL MESENCHYMAL TRANSITION; HCT116 CELL LINE; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MICROVILLUS; MTT ASSAY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SW480 CELL LINE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING; COLORECTAL NEOPLASMS; CULTURE MEDIUM; DRUG COMBINATION; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ALGINATES; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CULTURE MEDIA; DRUG THERAPY, COMBINATION; EPITHELIAL CELLS; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR JUNCTIONS; MESENCHYMAL STROMAL CELLS; STILBENES; UP-REGULATION;

EID: 84943582639     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.08.105     Document Type: Article

References (82)

1. A. Jemal, M.M. Center, E. Ward, and M.J. Thun Cancer occurrence Methods Mol. Biol. (Clifton, NJ) 471 2009 3 29
2. A.L. Pin, F. Houle, and J. Huot Recent advances in colorectal cancer research: the microenvironment impact Cancer Microenviron. 4 2011 127 131
3. T.A. Martin, and W.G. Jiang Loss of tight junction barrier function and its role in cancer metastasis Biochim. Biophys. Acta 1788 2009 872 891
4. N. Zhang, Y. Yin, S.J. Xu, and W.S. Chen 5-Fluorouracil: mechanisms of resistance and reversal strategies Mol. (Basel, Switzerland) 13 2008 1551 1569
5. J. Ren, J. Hamada, N. Takeichi, S. Fujikawa, and H. Kobayashi Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma Cancer Res. 50 1990 358 362
6. L.A. Staehelin Structure and function of intercellular junctions Int. Rev. Cytol. 39 1974 191 283
7. G.L. Nicolson, K.M. Dulski, and J.E. Trosko Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells Proc. Natl. Acad. Sci. U.S.A. 85 1988 473 476
8. L. Shen Tight junctions on the move: molecular mechanisms for epithelial barrier regulation Ann. N.Y. Acad. Sci. 1258 2012 9 18
9. A. Hartsock, and W.J. Nelson Adherens and tight junctions: structure, function and connections to the actin cytoskeleton Biochim. Biophys. Acta 1778 2008 660 669
10. C.M. Niessen Tight junctions/adherens junctions: basic structure and function J. Invest. Dermatol. 127 2007 2525 2532
11. L. Gonzalez-Mariscal, A. Betanzos, P. Nava, and B.E. Jaramillo Tight junction proteins Prog. Biophys. Mol. Biol. 81 2003 1 44
12. Z. Lu, L. Ding, Q. Lu, and Y.H. Chen Claudins in intestines: distribution and functional significance in health and diseases Tissue Barriers 1 2013 e24978
13. I. Van, C.M. tallie, and J.M. Anderson The molecular physiology of tight junction pores Physiology (Bethesda, Md) 19 2004 331 338
14. Q. Huo, T. Kinugasa, L. Wang, J. Huang, J. Zhao, H. Shibaguchi, and et al. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer Anticancer Res. 29 2009 851 857
15. P.P. Aung, Y. Mitani, Y. Sanada, H. Nakayama, K. Matsusaki, and W. Yasui Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas Virchows Arch. 448 2006 428 434
16. S.T. Mees, R. Mennigen, T. Spieker, E. Rijcken, N. Senninger, J. Haier, and et al. Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin Int. J. Colorectal Dis. 24 2009 361 368
17. J.R. Turner Intestinal mucosal barrier function in health and disease Nat. Rev. Immunol. 9 2009 799 809
18. J. Ikenouchi, M. Matsuda, M. Furuse, and S. Tsukita Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail J. Cell Sci. 116 2003 1959 1967
19. C.T. Capaldo, and A. Nusrat Cytokine regulation of tight junctions Biochim. Biophys. Acta 1788 2009 864 871
20. U. Tepass, K. Truong, D. Godt, M. Ikura, and M. Peifer Cadherins in embryonic and neural morphogenesis Nat. Rev. Mol. Cell Biol. 1 2000 91 100
21. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat. Rev. Cancer 2 2002 442 454
22. T. Ohkubo, and M. Ozawa The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation J. Cell Sci. 117 2004 1675 1685
23. L. Gonzalez-Mariscal, S. Lechuga, and E. Garay Role of tight junctions in cell proliferation and cancer Prog. Histochem. Cytochem. 42 2007 1 57
24. B.B. Aggarwal Nuclear factor-kappaB: the enemy within Cancer Cell 6 2004 203 208
25. P.A. Baeuerle, and D. Baltimore NF-kappa B: ten years after Cell 87 1996 13 20
26. B. Rayet, and C. Gelinas Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 1999 6938 6947
27. C.Y. Wang, J.C. Cusack Jr., R. Liu, and A.S. Baldwin Jr Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB Nat. Med. 5 1999 412 417
28. L. Baolin, Y. Inami, H. Tanaka, N. Inagaki, M. Iinuma, and H. Nagai Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro Planta Med. 70 2004 305 309
29. W. Li, J. Ma, Q. Ma, B. Li, L. Han, J. Liu, and et al. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-kappaB pathway Cur. Med. Chem. 20 2013 4185 4194
30. S.S. Kulkarni, and C. Canto The molecular targets of resveratrol Biochim. Biophys. Acta 2014
31. Z. Ren, L. Wang, J. Cui, Z. Huoc, J. Xue, H. Cui, and et al. Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities Pharmazie 68 2013 689 694
32. L. Li, J. Hai, Z. Li, Y. Zhang, H. Peng, K. Li, and et al. Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-alcoholic fatty liver disease Food Chem. Toxicol. 63 2014 166 173
33. C. Buhrmann, F. Busch, P. Shayan, and M. Shakibaei Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells J. Biol. Chem. 289 2014 22048 22062
34. S. Temraz, D. Mukherji, and A. Shamseddine Potential targets for colorectal cancer prevention Int. J. Mol. Sci. 14 2013 17279 17303
35. Y. Shukla, and R. Singh Resveratrol and cellular mechanisms of cancer prevention Ann. N.Y. Acad. Sci. 1215 2011 1 8
36. M.E. Juan, I. Alfaras, and J.M. Planas Colorectal cancer chemoprevention by trans-resveratrol Pharmacological Res. 65 2012 584 591
37. H. Wang, H. Zhang, L. Tang, H. Chen, C. Wu, M. Zhao, and et al. Resveratrol inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis Toxicology 303 2013 139 146
38. J. Li, T. Chong, Z. Wang, H. Chen, H. Li, J. Cao, and et al. A novel anticancer effect of resveratrol: reversal of epithelialmesenchymal transition in prostate cancer cells Mol. Med. Rep. 10 2014 1717 1724
39. Y. Yu, S.S. Kanwar, B.B. Patel, J. Nautiyal, F.H. Sarkar, and A.P. Majumdar Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX Trans. Oncol. 2 2009 321 328
40. M. Shakibaei, S. De, and P. ouza Differentiation of mesenchymal limb bud cells to chondrocytes in alginate beads Cell Biol. Int. 21 1997 75 86
41. M. Shakibaei, P. Kraehe, B. Popper, P. Shayan, A. Goel, and C. Buhrmann Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer BMC Cancer 15 2015 250
42. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 1984 27 55
43. T.C. Chou Drug combination studies and their synergy quantification using the Chou-Talalay method Cancer Res. 70 2010 440 446
44. P.R. Schneider, C. Buhrmann, A. Mobasheri, U. Matis, and M. Shakibaei Three-dimensional high-density co-culture with primary tenocytes induces tenogenic differentiation in mesenchymal stem cells J. Orthop. Res. 29 2011 1351 1360
45. M. Shakibaei, T. John, P. De Souza, R. Rahmanzadeh, and H.J. Merker Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor Biochem. J. 342 Pt 3 1999 615 623
46. M. Shakibaei, G. Schulze-Tanzil, S. de, P. ouza, T. John, M. Rahmanzadeh, R. Rahmanzadeh, and et al. Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes J. Biol. Chem. 276 2001 13289 13294
47. M. Shakibaei, C. Csaki, S. Nebrich, and A. Mobasheri Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis Biochem. Pharmacol. 76 2008 1426 1439
48. C. Csaki, A. Mobasheri, and M. Shakibaei Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis Arthritis Res. Ther. 11 2009 R165
49. F. van Roy, and G. Berx The cell-cell adhesion molecule E-cadherin Cell. Mol. Life Sci. 65 2008 3756 3788
50. X. Chen, Y. Wang, H. Xia, Q. Wang, X. Jiang, Z. Lin, and et al. Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis Mol. Biol. Rep. 39 2012 6707 6714
51. J.M. Lee, S. Dedhar, R. Kalluri, and E.W. Thompson The epithelial-mesenchymal transition: new insights in signaling, development, and disease J. Cell Biol. 172 2006 973 981
52. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, and et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927 939
53. A. Cano, M.A. Perez-Moreno, I. Rodrigo, A. Locascio, M.J. Blanco, M.G. del Barrio, and et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression Nat. Cell Biol. 2 2000 76 83
54. V. Bolos, H. Peinado, M.A. Perez-Moreno, M.F. Fraga, M. Esteller, and A. Cano The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors J. Cell Sci. 116 2003 499 511
55. M. Karin Nuclear factor-kappaB in cancer development and progression Nature 441 2006 431 436
56. R.Z. Orlowski, and A.S. Baldwin Jr. NF-kappaB as a therapeutic target in cancer Trends Mol. Med. 8 2002 385 389
57. S. Miyamoto, M. Maki, M.J. Schmitt, M. Hatanaka, and I.M. Verma Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B Proc. Natl. Acad. Sci. U.S.A. 91 1994 12740 12744
58. S. Ghosh, and M. Karin Missing pieces in the NF-kappaB puzzle Cell 109 Suppl 2002 S81 S96
59. X.Z. Ding, and T.E. Adrian Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells Pancreas 25 2002 e71 e76
60. K.B. Harikumar, A.B. Kunnumakkara, G. Sethi, P. Diagaradjane, P. Anand, M.K. Pandey, and et al. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer Int. J. Cancer 127 2010 257 268
61. S.L. Wu, Z.J. Sun, L. Yu, K.W. Meng, X.L. Qin, and C.E. Pan Effect of resveratrol and in combination with 5-FU on murine liver cancer World J. Gastroenterol. 10 2004 3048 3052
62. W.J. Nelson Adaptation of core mechanisms to generate cell polarity Nature 422 2003 766 774
63. E.E. Schneeberger, and R.D. Lynch The tight junction: a multifunctional complex Am. J. Physiol. Cell Physiol. 286 2004 C1213 C1228
64. D.F. Wallach Cellular membranes and tumor behavior: a new hypothesis Proc. Natl. Acad. Sci. U.S.A. 61 1968 868 874
65. W. Mueller-Klieser Multicellular spheroids. A review on cellular aggregates in cancer research J. Cancer Res. Clin. Oncol. 113 1987 101 122
66. C. Rahner, L.L. Mitic, and J.M. Anderson Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut Gastroenterology 120 2001 411 422
67. C. Buhrmann, P. Kraehe, C. Lueders, P. Shayan, A. Goel, and M. Shakibaei Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT PloS one 9 2014 e107514
68. K. Polyak, and R.A. Weinberg Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat. Rev. Cancer 9 2009 265 273
69. N.P. Gunasinghe, A. Wells, E.W. Thompson, and H.J. Hugo Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer Cancer Metastasis Rev. 31 2012 469 478
70. A. Bonnomet, L. Syne, A. Brysse, E. Feyereisen, E.W. Thompson, A. Noel, and et al. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer Oncogene 31 2012 3741 3753
71. M.T. Dimanche-Boitrel, L. Vakaet Jr., P. Pujuguet, B. Chauffert, M.S. Martin, A. Hammann, and et al. In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts Int. J. Cancer 56 1994 512 521
72. M. Barrios-Rodiles, K.R. Brown, B. Ozdamar, R. Bose, Z. Liu, R.S. Donovan, and et al. High-throughput mapping of a dynamic signaling network in mammalian cells Science (New York, N.Y.) 307 2005 1621 1625
73. S.C. Gupta, R. Kannappan, S. Reuter, J.H. Kim, and B.B. Aggarwal Chemosensitization of tumors by resveratrol Ann. N.Y. Acad. Sci. 1215 2011 150 160
74. D.B. Longley, D.P. Harkin, and J.P.G. ohnston 5-fluorouracil: mechanisms of action and clinical strategies Nat. Rev. Cancer 3 2003 330 338
75. F. Busch, A. Mobasheri, P. Shayan, C. Lueders, R. Stahlmann, and M. Shakibaei Resveratrol modulates interleukin-1beta-induced phosphatidylinositol 3-kinase and nuclear factor kappaB signaling pathways in human tenocytes J. Biol. Chem. 287 2012 38050 38063
76. M. Shakibaei, C. Buhrmann, and A. Mobasheri Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells J. Biol. Chem. 286 2011 11492 11505
77. M. Shakibaei, K.B. Harikumar, and B.B. Aggarwal Resveratrol addiction: to die or not to die Mol. Nutr. Food Res. 53 2009 115 128
78. M. Labelle, S. Begum, and R.O. Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 2011 576 590
79. M. Provinciali, F. Re, A. Donnini, F. Orlando, B. Bartozzi, S. Di, G. tasio, and et al. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice Int. J. Cancer 115 2005 36 45
80. M.A. Shibata, Y. Akao, E. Shibata, Y. Nozawa, T. Ito, S. Mishima, C. Vaticanol, and et al. a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation Cancer Chemother. Pharmacol. 60 2007 681 691
81. J.C. Chen, Y. Chen, J.H. Lin, J.M. Wu, and S.H. Tseng Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound Anticancer Res. 26 2006 1237 1245
82. S. Busquets, E. Ametller, G. Fuster, M. Olivan, V. Raab, J.M. Argiles, and et al. Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model Cancer Lett. 245 2007 144 148